ClinicalTrials.govpublic full text
Copanlisib and Gemcitabine in Relapsed/Refractory PTCL
mature t-cell and nk-cell neoplasm, copanlisib, gemcitabine, peripheral t-cell lymphoma, extranodal nk/t-cell lymphoma, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 847317
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.